Libas launches an e-commerce website
Libas launches an e-commerce website

Libas launches an e-commerce website

Siddhi Sharma Article rating: 5.0

NSE-listed company, Libas Consumer Products has announced its plans for expansion and with this, expects to clock in revenue of Rs 70 crore. 

Do you have any of these IT stocks that gained over 100 per cent up to 250 per cent in just 6 months?
Do you have any of these IT stocks that gained over 100 per cent up to 250 per cent in just 6 months?

Do you have any of these IT stocks that gained over 100 per cent up to 250 per cent in just 6 months?

BSE IT index outperformed the benchmark index-Sensex along with investors’ favourite BSE Small-Cap index in a bull market rally by gaining over 24 per cent in 2021

Abhinav Lahoti Article rating: 3.9

Amid the pandemic, just a few sectors were resilient and the IT sector was one of them. BSE IT index outperformed the benchmark index-Sensex along with investors’ favourite BSE Small-Cap index in a bull market rally by gaining over 24 per cent in 2021.

Alembic Pharma gets USFDA nod for manufacturing Erlotinib tablets
Alembic Pharma gets USFDA nod for manufacturing Erlotinib tablets

Alembic Pharma gets USFDA nod for manufacturing Erlotinib tablets

Shruti Dahiwal Article rating: 3.3

Alembic Pharmaceuticals Limited, a leading pharmaceutical company, announced today that it has received a go-ahead from United States Food & Drug Administration (USFDA) for manufacturing Erlotinib tablets. 

Five stocks witnessing long built-up
Five stocks witnessing long built-up

Five stocks witnessing long built-up

Ganesh Pawar Article rating: 4.2

The market opened in red on July 09, 2021, overall volumes in futures & options currently stand at 10,79,32,644 contracts with a turnover of Rs. 1,04,93,040.76 crore.

Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

Ganesh Pawar Article rating: 3.6

The market opened in red on July 09, 2021, overall volumes in futures & options currently stand at 10,79,32,644 contracts with a turnover of Rs. 1,04,93,040.76 crore.

RSS
First21392140214121422144214621472148Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR